Skip to main content

Steroids in Spinal Injury...waiting more evidence



The Use of steroids in Spinal cord trauma/injury is controversial topic ,some still belief it is helpful, and surely there are opponents who belief the opposite..the question what is the evidence?
here were we are putting some of the literature findings...some findings support and another don't..

The original NASCIS trial (NASCIS I) found no difference in motor function or pinprick/sensation from baseline with IV methylprednisolone use, but the doses used were much lower than the doses used in the animal studies that first suggested a possible benefit. 

Therefore, NASCIS II was performed to look at high dose methylprednisolone in acute spinal cord injury.  Patients received either methylprednisolone, naloxone, or placebo within the first twelve hours of injury.  The methylprednisolone was high dose and given for 24 hours.  Overall there was no benefit in the methylprednisolone group, but sub-group analysis showed a small benefit in motor function in the patients that received the IV steroids within the first 8 hours. 

After that study, many began to define high dose methylprednisolone as standard of care after acute spinal cord injury. 

A Japanese study  attempted to repeat the NASCIS II using the 8 hour timeline as the main outcome, and it showed a benefit. 

 However, the opponents of steroids in acute spinal cord injury noted that the randomization was not defined and only 3/4 of the patients enrolled were listed in the data. 

NASCIS III attempted to compare a 24 hour regiment with a 48 hour regimen and found no benefit.

In the US, a survey of spine surgeons reported 91% of them use steroids in acute spinal cord injury, although only 24% of them believe there is a clinical benefit.  Once the label of “standard of care” is attached, it’s hard to remove. 

The Cochrane review reported that high-dose methylprednisolone is the only approved pharmacologic treatment of acute spinal cord injury that has been proven by prospective, randomized studies.  The review admitted the treatment must be started within 8 hours to see the benefit, but it didn’t mention the post-hoc analysis aspect. 

The Canadians no longer define steroids as a standard of care but instead call it a treatment option. 

 Until better data emerge, we’re still forced to decide between a possible benefit from post-hoc analysis vs going against a “standard of care.


Bracken, et al.  A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury — Results of the Second National Acute Spinal Cord Injury Study.  N Engl J Med.  1990; 322:1405-1411.

Young, Bracken, et al.  The Second National Acute Spinal Cord Injury Study.  J Neurotrauma.  1992, 9 Suppl 1:S397-405.

Bracken, et al.  Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury.  JAMA.  1997;277(20):1597-1604
Labels:

Comments

Post a Comment

Popular posts from this blog

Driving Pressure in ARDS: A new concept!

Driving Pressure and Survival in the Acute Respiratory Distress Syndrome Marcelo B.P. Amato, M.D., Maureen O. Meade, M.D., Arthur S. Slutsky, M.D., Laurent Brochard, M.D., Eduardo L.V. Costa, M.D., David A. Schoenfeld, Ph.D., Thomas E. Stewart, M.D., Matthias Briel, M.D., Daniel Talmor, M.D., M.P.H., Alain Mercat, M.D., Jean-Christophe M. Richard, M.D., Carlos R.R. Carvalho, M.D., and Roy G. Brower, M.D. N Engl J Med 2015; 372:747-755 February 19, 2015 DOI: 10.1056/NEJMsa1410639 BACKGROUND Mechanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V T ), and higher positive end-expiratory pressures (PEEPs) can improve survival in patients with the acute respiratory distress syndrome (ARDS), but the relative importance of each of these components is uncertain. Because respiratory-system compliance (C RS ) is strongly related to the volume of aerated remaining functional lung during disease (termed functional lung size)...
5 comments
Read more

Anaphylaxis updates part 2- Empty Ventricle Syndrome

Patients with anaphylaxis should not suddenly sit, stand, or be placed in the upright position. Instead, they should be placed on the back with their lower extremities elevated or, if they are experiencing respiratory distress or vomiting, they should be placed in a position of comfort with their lower extremities elevated. This accomplishes 2 therapeutic goals: 1) preservation of fluid in the circulation (the central vascular compartment), an important step in managing distributive shock; and 2) prevention of the empty vena cava/empty ventricle syndrome, which can occur within seconds when patients with anaphylaxis suddenly assume or are placed in an upright position. Patients with this syndrome are at high risk for sudden death. They are unlikely to respond to epinephrine regardless of route of administration, because it does not reach the heart and therefore cannot be circulated throughout the body
Post a Comment
Read more

Steroids In Perioperative period...The Multi-purpose Drugs

1-Steroids are not Bronchodilator ,but have well established usefulness in hyper-reactive airway. They are also said to have a permissive role for bronchodilator medication. They can be administered orally, parenterally or in aerosol form 2- Steroids have been commonly used in chemotherapy for prevention of nausea along with other anti-emetic agents . Dexamethasone was found to be highly effective when given immediately before induction rather than at the end of anesthesia . 3- Steroids do exert analgesic effects. Various routes of administration of steroids include parentral, local infiltration at operated site , as an adjuvant in nerve blocks and central-neuraxial blockade. 4 - Steroids cannot be the mainstay of therapy in anaphylaxis because of the delayed onset of action, so they are used as adjunct after initial treatment with epinephrine. 5- Steroids (Dexamethsone) are of value in reduction or prevention of cerebral edema associated with parasitic infections and neopla...
1 comment
Read more